Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on H Acid. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN102936214A details a clean H acid synthesis via catalytic hydrogenation and mother liquor recycling, offering significant waste reduction and yield improvements for dye manufacturers.
Patent CN106674264A reveals high-yield route for pharmaceutical intermediates. Enhances supply chain reliability and reduces manufacturing costs significantly.
Patent CN105755095A enables high-yield enzymatic deracemization. Delivers cost reduction and supply chain reliability for pharmaceutical intermediates manufacturing globally.
Patent CN107988307A details enzymatic resolution for high-purity intermediates. This method offers significant supply chain reliability and cost reduction in pharmaceutical manufacturing.
Patent CN113355367B reveals high-efficiency LlKAR enzyme for deracemization. Offers significant cost reduction and supply chain reliability for pharmaceutical intermediates manufacturing.
Patent CN102336703B details a green Bi2O3-catalyzed oxidation and HATU coupling route for Roflumilast, offering superior yield and supply chain reliability for global pharma buyers.
Patent CN114394913B introduces a metal-free heteropolyacid catalyzed synthesis of oxime ethers. This method offers significant cost reduction and environmental benefits for pharmaceutical intermediate manufacturing.
Patent CN114958699A reveals a novel dual-enzyme co-expression strategy for ursodeoxycholic acid, offering superior purity and cost reduction in pharmaceutical intermediates manufacturing.
Patent CN109665999B details a novel U-type template strategy for meta-selective C-H activation, offering cost reduction in API manufacturing and scalable routes for high-purity intermediates.
Advanced stereoselective synthesis of Phencyclonate optical isomers via Mandelic acid template. Superior purity and scalable route for pharmaceutical manufacturing.
Patent CN115181031A reveals a low-cost chlorination route for chlorantraniliprole intermediates using sulfuryl chloride, offering high purity and scalable manufacturing.
Novel synthetic route for 5-trifluoromethyl pyrrole-2-formic acid via sodium triflinate. Improved yield and purification for reliable pharma intermediate supply.
Patent CN102382091A reveals a mild one-step route to chromones using benzyne chemistry, offering cost reduction in API manufacturing and reliable supply.
Patent CN113185439B reveals scalable chiral ligand synthesis reducing costs and enhancing supply chain reliability for complex pharmaceutical manufacturing processes.
Novel HT-Fen ester synthesis patent CN105753702B offers multi-target metabolic benefits. Scalable route ensures supply continuity for pharma partners.
Patent CN102399205A details methanol-based purification enhancing purity and reducing solvent waste for scalable API manufacturing supply chains. This report analyzes technical feasibility for global procurement.
Novel patent CN119191963A enables high-yield synthesis of 5-formyl-2-4-dimethylbenzoic acid. Reduces costs and improves supply chain reliability for pharmaceutical intermediates.
Patent CN113423714A details a novel sulfonylation route for 3'-O-amino-ribonucleotides, offering improved selectivity and scalability for nucleic acid manufacturing.
Patent CN1653029A details a novel synthesis reducing metal impurities. Ideal for reliable electronic chemical and API intermediate manufacturing with enhanced purity profiles.
Patent CN103626791A details a cost-effective synthesis of 3-amino-4-fluorophenylboronic acid via Grignard borylation, offering significant supply chain advantages for pharmaceutical intermediates.